Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Evans, UT
Andrea Maren Evans, Sandy, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20100266693 | Controlled release local anesthetic comprising a biologically active non-sulfated glycosaminoglycan matrix - The invention relates to structuring a combination of bioactive materials that are capable of controlled extended release of local anesthesia lasting over 30 hours. | 10-21-2010 |
Bruce G. Evans, Sandy, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20090324683 | CONTROLLED RELEASE TISSUE GRAFT COMBINATION BIOMATERIALS - In one aspect, the invention relates to tissue graft combination biomaterials capable of controlled release of bioactive agents or pharmaceutically active agents through a rate-controlling polymer coating encapsulating the graft material, methods for preparing same, methods of controlled release using same, and methods for treating tissue defects. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. | 12-31-2009 |
David Christopher Evans, Sandy, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20090324683 | CONTROLLED RELEASE TISSUE GRAFT COMBINATION BIOMATERIALS - In one aspect, the invention relates to tissue graft combination biomaterials capable of controlled release of bioactive agents or pharmaceutically active agents through a rate-controlling polymer coating encapsulating the graft material, methods for preparing same, methods of controlled release using same, and methods for treating tissue defects. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. | 12-31-2009 |
| 20100266693 | Controlled release local anesthetic comprising a biologically active non-sulfated glycosaminoglycan matrix - The invention relates to structuring a combination of bioactive materials that are capable of controlled extended release of local anesthesia lasting over 30 hours. | 10-21-2010 |
David P. Evans, Salt Lake City, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20080294469 | Travel Service Aggregator - The subject matter of this specification can be embodied in, among other things, a system that includes a user interface to receive an electronic status change for an airline flight and an airline reservation system to determine whether at least one ancillary travel service associated with the airline flight should be modified based on the received electronic status change. The system includes a messaging interface to electronically transmit a request to modify the at least one ancillary travel service based on the electronic status change if the determination is made to modify the at least one ancillary travel service. The messaging interface further electronically transmits payment information to the travel service provider for use in crediting or debiting a payment associated with the at least one modified ancillary travel service. The payment information is associated with a customer that reserved the at least one ancillary travel service. | 11-27-2008 |
| 20090055271 | TRAVEL REWARD ACCRUAL - The subject matter of this specification can be embodied in, among other things, a method that includes receiving an indication that a passenger is boarding a carrier for a first segment of a travel itinerary, determining an amount of travel reward points to associate with the first segment, and outputting, at a time substantially concurrent with the boarding of the carrier for the first segment, the amount of the travel reward points to a travel reward system so that the travel reward points are available for redemption by the passenger on a second segment of the travel itinerary. | 02-26-2009 |
Grant Evans, Provo, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20120121951 | Battery with an Internal Heating Element - In one aspect of the invention, a rechargeable battery has a cathode cavity formed in a cathode housing and a anode cavity in a anode housing. A moveable membrane is disposed between the cathode cavity and the anode cavity. The cathode cavities are filled with an electrolyte. | 05-17-2012 |
| 20120121960 | Battery with a Moveable Membrane Separating a Cathode and Anode Cavity - In one aspect of the invention, a rechargeable battery has a cathode cavity formed in a cathode housing and a anode cavity in a anode housing. A moveable membrane is disposed between the cathode cavity and the anode cavity. The cathode cavities are filled with an electrolyte. | 05-17-2012 |
| 20120121961 | Battery with an Internal Compressible Mechanism - In one aspect of the invention, a rechargeable battery has a cathode cavity formed in a cathode housing and a anode cavity in a anode housing. A moveable membrane is disposed between the cathode cavity and the anode cavity. The cathode cavities are filled with an electrolyte. | 05-17-2012 |
Jaden Duss Evans, Centerville, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20110176996 | COMPOSITIONS AND METHODS FOR CANCER MANAGEMENT USING ANTIBODIES BINDING TO NUCLEOTIDE SALVAGE PATHWAY ENZYMES AND COMPLEXES THEREOF - Compositions and methods are provided for the diagnosis, treatment, and medical management of cancers. The methods include the use of antibodies and other binding molecules that specifically bind to one or more nucleotide salvage pathway enzymes (SPEs) selected from the group consisting of adenine phosphoribosyltransferase (APRT), hypoxanthine-guanine phosphoribosyltransferase (HGPRT), deoxycytidine kinase (dCK); and thymidine kinase 1 (TK1) and complexes comprising SPEs, for detection of the SPE(s) on or in cancer cells and/or on or in body fluids and tissues of cancer patients. Binding of SPEs is useful in the methods provided herein for diagnosing cancer, determining prognosis of cancer and assessing the effectiveness of cancer treatments. Immunoassay systems for use in the methods are also provided, including sandwich immunoassays. In addition, an amino acid sequence comprising a novel TK1 binding site is provided, as well as nucleotide sequences encoding it. | 07-21-2011 |
John Evans, Riverton, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20100119056 | ATTENUATION AND TERMINATION CIRCUIT USING IMPEDANCE SYNTHESIS - The present invention discloses circuits for isolating and attenuating signals generated by a telephone network. In disclosed embodiments, a metering pulse signal is isolated from the terminals of the connecting device, and then attenuated with an impedance that is synthesized with a programmable digital signal processor. Embodiments also utilize the digital signal processor to synthesize a termination impedance for the connecting device. The termination impedance matches closely the characteristic impedance of the network, so as to minimize wave reflections and the like. | 05-13-2010 |
John G. Evans, South Jordan, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20090156928 | RADIOPAQUE AND SEPTUM-BASED INDICATORS FOR A MULTI-LUMEN IMPLANTABLE PORT - An implantable multi-lumen access port including indicators for ascertaining characteristics of the port is disclosed. In one embodiment, the access port comprises a housing that defines a first reservoir and a second reservoir. A first septum and second septum are respectively coupled with the housing to provide selective access to the first and second reservoirs. Each septum includes a plurality of protrusions defined about a periphery thereof that are palpable after implantation of the port in a patient to determine a relative position of the first septum with respect to the second septum. A radiographically observable indicator is also included on a base of the housing, so as to provide information relating to a characteristic of the dual-lumen port, such as suitability for power injection of fluids. The indicator in one embodiment includes a substantially rigid radiopaque component. | 06-18-2009 |
| 20090204074 | METHODS OF POWER INJECTING A FLUID THROUGH AN ACCESS PORT - Methods of power injecting a fluid through an access port are described. One method includes implanting in a patient an access port suitable for passing fluid therethrough at a rate of at least about 1 milliliter per second, the access port including a body defining a cavity, a septum, and an outlet in fluid communication with the cavity, and flowing a fluid through an infusion set into the access port at a rate of at least about 1 milliliter per second, the infusion set including a needle in fluid communication with a tubing, the tubing in fluid communication with a connector, each of the needle, tubing, and connector constructed to have a burst pressure of at least about 100 psi. | 08-13-2009 |
| 20100069743 | SYSTEMS AND METHODS FOR IDENTIFYING AN ACCESS PORT - An access port for subcutaneous implantation is disclosed. Such an access port may comprise a body for capturing a septum for repeatedly inserting a needle therethrough into a cavity defined within the body. Further, the access port may include at least one feature structured and configured for identification of the access port subsequent to subcutaneous implantation. Methods of identifying a subcutaneously implanted access port are also disclosed. For example, a subcutaneously implanted access port may be provided and at least one feature of the subcutaneously implanted access port may be perceived. Further, the subcutaneously implanted access port may be identified in response to perceiving the at least one feature. In one embodiment, an identification feature is engraved or otherwise defined by the access port, so as to be visible after implantation via x-ray imaging technology. | 03-18-2010 |
| 20100121283 | IMPLANTABLE MEDICAL DEVICES INCLUDING SEPTUM-BASED INDICATORS - An access port for providing subcutaneous access to a patient is disclosed. The access port includes a septum including palpable identification indicia thereon. In particular, the access port in one embodiment includes a body that defines a fluid cavity and a needle-penetrable septum covering the fluid cavity for providing access thereto. The septum defines an outer periphery. One or more palpation features are included on the septum. The palpation features each include a portion that extends in a radial direction beyond the outer periphery of the septum. The palpation features are therefore disposed relatively farther away from each other, simplifying palpation and identification thereof after the port has been subcutaneously implanted into a patient. The palpation features can be indicative of an attribute of the port, such as its ability to withstand fluid pressures and flow rates associated with power injection, for instance. | 05-13-2010 |
Mark Gordon Evans, Sandy, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20100266693 | Controlled release local anesthetic comprising a biologically active non-sulfated glycosaminoglycan matrix - The invention relates to structuring a combination of bioactive materials that are capable of controlled extended release of local anesthesia lasting over 30 hours. | 10-21-2010 |
Matthew R. Evans, Draper, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20100306194 | Recommendation network - A recommendation network is described. In some embodiments, the recommendation network includes recommenders that explicitly or implicitly recommend, rate or refer items and recommendation receivers that receive the recommendations. In some embodiments, the recommenders can be recommendation receivers, and vice versa. In some embodiments, recommendation receivers assign rust ratings to recommenders. The recommendation receiver can assign separate trust ratings to individual topics for which the recommendation receiver trusts the recommender. The separate trust ratings represent the recommendation receiver's amount of trust in the recommender to makes valuable recommendations for the specific topic. The recommendation network can use the separate trust ratings, along with ratings provided by the recommender, to rank recommendations per the separate topics. The recommendation receiver can assign the recommender to different bundles, topics, channels, etc. to which other recommendation receivers can subscribe. | 12-02-2010 |
Richard O. Evans, Hyrum, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20080300114 | ELLIPTICAL EXERCISE MACHINE WITH ADJUSTABLE RAMP - An elliptical exercise machine with adjustable ramp is provided and comprises a frame, first and second reciprocating foot supports, each foot support having a foot placement pad, first and second swing arms being pivotally connected to an upright support structure, first and second link arms being connected to a respective swing arm and a second end of each link arm being interconnected to a second end of a respective reciprocating foot support, a drive assembly positioned on the upright support structure, wherein a first end of each reciprocating foot support is movably linked to the drive assembly, and a ramp assembly adjustably linked to the frame by an adjustment mechanism coupled to the frame and the ramp assembly, the adjustment mechanism being configured to adjust the position of the ramp assembly and to thereby adjust stride movements of the respective foot placement pads. | 12-04-2008 |
Tyler Evans, Salt Lake City, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20090193961 | Apparatus, System, and Method for Filamentary Composite Lattice Structure Manufacturing - An apparatus, system, and method are disclosed for the manufacture of composite lattice structures comprising a weaving mechanism | 08-06-2009 |
Tyler Evans, Provo, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20100057004 | Extravascular System In-Line Venting - An extravascular system may include a fluid path and a gas vent in communication with the fluid path. A method of venting a medical device may include providing a closed extravascular system having a fluid path, providing a gas vent in communication with the fluid path, venting gas from the extravascular system through the gas vent, and maintaining closure of the extravascular system during and after venting. | 03-04-2010 |